U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06873425) titled 'Research on the Improvement of Intestinal and Immune Functions by Probiotics' on March 03.

Brief Summary: Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Study Start Date: March 10

Study Type: INTERVENTIONAL

Condition: Intestinal Health

Intervention: DIETARY_SUPPLEMENT: Probiotic

Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

DIETARY_SUPPLEMENT: Placebo

Dietary ...